Market Outlook
The global cancer supportive care drugs market stood at a value of almost USD 22.3 billion in 2018. The market is expected to witness a steady growth during the forecast period of 2019-2024, growing at a CAGR of 1.2%. It is estimated that the global cancer burden has risen to 18.1 million new cases and 9.6 million deaths in 2018. The most prominent kinds of cancer with the greatest demand for supportive care drugs are lung and breast cancer.
Read full report with table of content - https://www.expertmarketresearch.com/reports/cancer-supportive-care-drugs-market